These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 79342)

  • 41. Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation).
    Rochefort H; Capony F
    Biochem Biophys Res Commun; 1977 Mar; 75(2):277-85. PubMed ID: 557979
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of estradiol-induced intranuclear inclusions by an anti-estrogen (nafoxidine) in mammotrophs of the Mongolian gerbil.
    Nickerson PA
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):29-30. PubMed ID: 1129319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of action of estrogen agonists and antagonists.
    Clark JH; Hardin JW; McCormack SA
    J Anim Sci; 1979; 49 Suppl 2():46-65. PubMed ID: 400777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in brain, pituitary and uterine cytoplasmic oestrogen receptors induced by oestradiol-17beta in the ovariectomized rat.
    Morris ID
    J Endocrinol; 1976 Dec; 71(3):343-9. PubMed ID: 1003063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone acetylation and hormone action. Early effects of oestradiol-17beta on histone acetylation in rat uterus.
    Libby PR
    Biochem J; 1972 Dec; 130(3):663-9. PubMed ID: 4664926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapeutic agents and estradiol receptor binding capacity.
    Görlich M; Heise E; Számel I; Kerpel-Fronius S
    Oncology; 1979; 36(4):149-55. PubMed ID: 471426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Musculinization and defeminization induced in female hamsters by neonatal treatment with estradiol, RU-2858, and nafoxidine.
    Etgen AM; Whalen RE
    Horm Behav; 1979 Jun; 12(3):211-7. PubMed ID: 546708
    [No Abstract]   [Full Text] [Related]  

  • 48. Anti-oestrogenic effects of nafoxidine on the synthesis of DNA by the rat pituitary gland.
    Jacobi JM; Lloyd HH
    J Endocrinol; 1978 Mar; 76(3):555-6. PubMed ID: 632729
    [No Abstract]   [Full Text] [Related]  

  • 49. Antioestrogenic derivatives of nafoxidine stimulate progesterone receptor synthesis in vivo [proceedings].
    Allen KE; Jordan VC
    Br J Pharmacol; 1980 Jan; 68(1):156P-157P. PubMed ID: 7357169
    [No Abstract]   [Full Text] [Related]  

  • 50. Female steroid hormones and lipoprotein synthesis in the cockerel: effects of progesterone and nafoxidine on the estrogenic stimulation of very low density lipoproteins (VLDL) synthesis.
    Chan L; Jackson RL; Means AR
    Endocrinology; 1977 Jun; 100(6):1636-43. PubMed ID: 192542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationships between the effects of the anti-estrogen, CI-628, on sexual behavior, uterine growth, and cell nuclear estrogen retention after estradiol-17beta-benzoate administration in the ovariectomized rat.
    Landau IT
    Brain Res; 1977 Sep; 133(1):119-38. PubMed ID: 902080
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of antiestrogens on the nuclear binding of the estrogen receptor.
    Ruh TS; Ruh MF
    Steroids; 1974 Aug; 24(2):209-24. PubMed ID: 4370897
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of nafoxidine and oestriol on the oestradiol-induced activation of rat liver tryptophan oxygenase and tyrosine aminotransferase and increase in uterine weight.
    Hamburger AD
    Biochem Pharmacol; 1981 Sep; 30(17):2485-8. PubMed ID: 21043251
    [No Abstract]   [Full Text] [Related]  

  • 54. Gap junction modulation in rat uterus. III. Structure-activity relationships of estrogen receptor-binding ligands on myometrial and serosal cells.
    Burghardt RC; Gaddy-Kurten D; Burghardt RL; Kurten RC; Mitchell PA
    Biol Reprod; 1987 Apr; 36(3):741-51. PubMed ID: 3593845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple forms of nuclear estrogen receptor in the immature rat uterus after in vitro exchange with [3H]estradiol or [3H] antiestrogens.
    Attardi B
    Mol Cell Endocrinol; 1983 Feb; 29(2):159-67. PubMed ID: 6832469
    [No Abstract]   [Full Text] [Related]  

  • 56. Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol.
    Nirmala PB; Thampan RV
    Biochem Biophys Res Commun; 1995 Aug; 213(1):24-31. PubMed ID: 7639742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of rotenone to interfere with 17 beta-estradiol action in the rat uterus.
    Olson ME; Sheehan DM
    Cancer Res; 1979 Nov; 39(11):4438-40. PubMed ID: 498075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The nuclear oestrogen receptor in the female rat. Effects of oestradiol administration during the oestrous cycle on the uterus and contrasting effects of progesterone on the uterus and hypothalamus.
    Thrower S; Lim L
    Biochem J; 1981 Aug; 198(2):385-9. PubMed ID: 7198913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    Sato M; Rippy MK; Bryant HU
    FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.